跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Brusatol
首页
药物
Brusatol
Brusatol
未知生产厂商
订阅
生成 AI 研报
Share to Twitter
Share to Facebook
Share to LinkedIn
Share to Reddit
摘要
临床试验
审批记录
专利
每项发明一条,涵盖美国、欧洲、PCT 与中国的同族专利。
Cancer chemopreventative compounds and compositions and methods of treating cancers
US 2002193425 A1
申请人: PEZZUTO JOHN M
优先权: 2002
US
US 2003149096 A1
申请人: PEZZUTO JOHN M
优先权: 2002
US
Use of brusatol in preparation of drugs for resisting tumor angiogenesis
CN 106551926 A
申请人: UNIV NANTONG
优先权: 2015
CN
Application of brusatol in preparation of a TLR4/NF-kB pathway inhibitor and a medicine for treating inflammatory bowel disease
CN 106924245 A
申请人: UNIV GUANGZHOU CHINESE MEDICINE
优先权: 2017
CN
Medicine or composition for treating breast cancer
CN 110935018 A
申请人: UNIV XINXIANG MEDICAL
优先权: 2019
CN
Application of brusatol in preparing medicament for preventing or/and treating inflammatory diseases
CN 111184714 A
申请人: UNIV CHONGQING
优先权: 2020
CN
Application of brusatol
CN 113521043 A
申请人: UNIV KUNMING MEDICAL
优先权: 2020
CN
Application of brusatol to preparation of medicine for treating cerebral arterial thrombosis
CN 113143914 A
申请人: UNIV NANTONG
优先权: 2021
CN
Application of brusatol in preparation of medicine for inhibiting glycolysis metabolism and mitochondrial respiration of oral squamous carcinoma cells
CN 113368105 A
申请人: BEIJING STOMATOLOGICAL HOSPITAL CAPITAL MEDICAL UNIV
优先权: 2021
CN
Brusatol在制备抗辐射损伤药物中的应用
CN 114028387 B
申请人: 中国人民解放军军事科学院军事医学研究院
优先权: 2022
CN
Application of brusatol in preparation of anti-NSCLC medicine
CN 115737634 A
申请人: FIRST AFFILIATED HOSPITAL WENZHOU MEDICAL UNIV
优先权: 2022
CN
第 1 / 2 页
上一页
下一页
药物
反馈